Global burden of cancer

Lancet

Volumn 349, Issue SUPPL.2, 1997, Pages

  Boyle, Peter ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; ESOPHAGUS CANCER; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; LIVER CANCER; MALE; MELANOMA; PRIORITY JOURNAL; PROSTATE CANCER; SHORT SURVEY; UTERINE CERVIX CANCER;

EID: 0030956045     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(97)90017-9     Document Type: Article

References (49)

1. Parkin DM, Stjernsward J, Muir CS. Estimates of the world wide frequency of twelve major cancers. Bull World Health Organ 1984; 62: 163-82.
2. Parkin DM, Láára E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184-97.
3. Parkin DM, Ferlay J, Pisani P. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
4. Chollat-Traquet C. Women and tobacco. Geneva: WHO, 1992.
5. Brody J. Prospects for an ageing population. Nature 1985; 315: 463-66.
6. Day NE, Munoz N: Esophagus. In: Scottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention. Philadelphia: Saunders, 1982: 596-622.
7. Lu JB, Yang WX, Liu JM, et al Trends in morbidity and mortality for esophageal cancer in Linxian county, 1959-1983. Int J Cancer 1985; 36: 643-645.
8. Muir CS, Waterhouse J, Mack T, Powell J, Whelan S, eds. Cancer incidence in five continents. Vol V. Lyon: IARC Scientific Publications no 88, 1987.
9. Kmet J, Mahboubi E. Esophageal cancer in the Caspian littoral of Iran: initial studies. Science 1972; 175: 846-53.
10. Smans M, Boyle P, Muir CS, eds. Cancer mortality atlas of EEC. Lyon: IARC, Scientific Publication no 107, 1993.
11. Parkin DM, Muir CS, Whelan S, Gao YT, Ferlay J, Powell J, eds. Cancer incidence in five continents. Vol VI. Lyon: IARC, Scientific Publication no 120, 1992.
12. Napalkov NP, Tserkovy GF, Merabishuili VM, Parkin DN, Smans M, Muir CS, eds. Cancer incidence in the USSR (supplement to cancer incidence in five continents. Vol III). Lyon: IARC, Scientific Publications no 48, 1983.
13. Boyle P, Maisonneuve P, Levi F, et al. Cancer patterns in central and Eastern Europe: comparison with the rest of Europe. In: Bodmer W, Zaridze DG, eds. Cancer prevention in Central and Eastern Europe. Geneva: UICC, 1993.
14. Vigotti MA, Cislaghi C, Balzi D, et al. Cancer mortality in migrant populations within Italy. Tumori 1988; 74: 107-28.
15. Srivatanakul S, Sontipong P, Chotiwan P, Parkin DM. Liver cancer in Thailand: temporal and geographic variations. J Gastroenterol Hepatol 1988; 3: 413-420.
16. McCredie M, Coates MS, Ford JM. Cancer incidence in European migrants to New South Wales. Ann Oncol 1990; 1: 219-25.
17. Muir CS, Nectoux J. Time trends, malignant melanoma of the skin. In: Magnus K, ed. Trends in cancer incidence. New York: Plenum Press, 1982: 365-85.
18. Van der Esch EP, Muir CS, Nectoux J, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991; 47: 483-89.
19. IARC Working Group on Cervical Cancer Screening. Summary chapter. In: Hakama M, Miller AB, Day NE, eds. Screening for cancer of the uterine cervix. Lyon: IARC, Scientific Publications no 76, 1986: 133-42.
20. Muñoz N, Bosch FX. Epidemiology of cervical cancer. In: Muñoz N, Bosch FX, Jensen OM, eds. Human papillomavirus and cervical cancer. Lyon: IARC, Scientific Publications no 94, 1989: 9-39.
21. Breslow N, Chan CE, Dhom G, et al. Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 1977; 20: 680-88.
22. Clemmesen J. Statistical studies in malignant neoplasms I: review and results. Copenhagen: Munksgaard, 1965.
23. Schairer C, Hartge P, Hoover RN, Silverman DT. Racial differences in bladder cancer risk: a case-control study. Am J Epidemiol 1988; 128:1027-37.
24. Miller AB, Chamberlain J, Day NE, Hakama M, Prorock PC. Cancer screening. Geneva: UICC, 1991.
25. Fahs MC, Mandelblatt J, Schechter C, Muller C. Cost effectiveness of cervical cancer screening in the elderly. Ann Intern Med 1992; 117: 520-27.
26. Hakama M, Magnus K, Petterson F, Storm H, Tulinius H. Effect of organised screening on the risk of cervix cancer in the Nordic countries. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorock PC, eds. Cancer screening. Geneva: UICC, 1991.
27. Cuzick J, Szarewski A, Terry G, et al. Human papillomavirus testing in primary cervical screening. Lancet 1995; 345:1533-36.
28. Wald NJ, Chamberlain J, Hackshaw A, et al. Report of the European Society of Mastology (EUSOMA) Breast Cancer Screening Evaluation Committee. Breast 1993; 2: 209-16.
29. Chen HH, Duffy SW, Tabar L, Day NE. Markov chain models for progression of breast cancer part I: tumour attributes and the pre-clinical screen-detectable phase. J Epidemiol Biostat (in press).
30. Chen HH, Duffy SW, Tabar L, Day NE. Markov chain models for progression of breast cancer part II: tumour attributes and the preclinical screen-detectable phase. J Epidemiol Biostat (in press).
31. Swedish Cancer Society and the Swedish National Board of Health and Welfare. Breast-cancer screening with mammography in women aged 40-49 years. Int J Cancer 1996; 68: 693-99.
32. Anonymous. The breast-screening brawl. Science 1997; 275: 1056-59.
33. Thomas DB, Gao DL, Self SG, et al. Randomized trial of breast examination in Shanghai: methodology and preliminary results. J Natl Cancer Inst 1997; 89: 355-65.
34. Semiglazov VF, Sagaidak VN, Moiseyenko VM, Mikhailov EA. Study of the role of breast self-examination in the reduction of mortality from breast cancer: the Russian Federation/ World Health Organisation Study. Eur J Cancer 1993; 29: 2039-46.
35. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer: a case-control study. Ann Intern Med 1993; 118: 1294-97.
36. Wahrendorf J, Robra BP, Wiebelt H, Oberhausen R, Weiland M, Dhom G. Effectiveness of colorectal cancer screening: a population-based case-control study in Saarland, Germany. Eur J Cancer Prev 1993; 1: 221-27.
37. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365-71.
38. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-77.
39. Kronberg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71.
40. Hardcastle JD. Screening for colorectal cancer. Lancet 1997; 349: 358.
41. Boyle P. Progress in preventing death from colorectal cancer. Br J Cancer 1995; 72: 528-30.
42. Mandel J. Colon and rectal cancer.. In: Reinigen DS, Clark RA, eds. Cancer screening. St Louis: Mosby, 1996: 55-96.
43. Catalona WJ. Prostate cancer. In: Reinigen DS, Clark RA, eds. Cancer screening. St Louis: Mosby, 1996: 97-117.
44. Chamberlain J, Melia J. Cancer of the prostate. In: Chamberlain J, Moss S, eds. Evaluation of cancer screening. Berlin: Springer, 1996: 117-36.
45. Collins MM, Barry MJ. Controversies in prostate cancer screening, analogies to the early lung cancer screening debate. JAMA 1996; 276: 1976-79.
46. Chamberlain J, Moss S, eds. Evaluation of cancer screening. Berlin: Springer, 1996.
47. Reintgen DS, Clark RA, eds. Cancer screening. St Louis: Mosby, 1996.
48. La Vecchia C, Lucchini F, Negri E, Boyle P, Levi F. Trends in cancer mortality in the Americas, 1955-1989. Eur J Cancer 1993; 29A: 431-70.
49. Boyle P. Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Consensus Meeting. Helsinki, October 1996. Lung Cancer (in press).